Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
415 Mutations in FBXO38, a component of the SCF E3 ubiquitin ligase complex, dampen anti-tumor immunity
- 1University of Chicago, Chicago, IL, USA
Related
- Rifabutin Cross-resistance and Associated rpoB Mutations in Rifampicin-resistant Mycobacterium tuberculosis Complex Isolates
- RNA splicing factor mutations drive myeloid neoplasm oncogenesis through protein complex poisoning
- A Salivary Conglomerate with a Substantial Organic Component Mimicking a Mineral Sialolith in the Mandibular-Sublingual Gland Complex of a Dog.
- Guided Growth as a Component of Joint-Preserving Management of Complex Osteoarticular Pathology in the Growing Knee: A Pediatric Case Report
- Dismantling Psychological Interventions for Youth with Complex Trauma: A Systematic Review and Component Network Meta-Analysis.
BibTeX
@article{barrett2026mutations,
title = {{415 Mutations in FBXO38, a component of the SCF E3 ubiquitin ligase complex, dampen anti-tumor immunity}},
author = {Stephen C Barrett and Thomas F Gajewski},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0415},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0415},
note = {CC BY},
}
RIS
TY - JOUR
TI - 415 Mutations in FBXO38, a component of the SCF E3 ubiquitin ligase complex, dampen anti-tumor immunity
AU - Stephen C Barrett
AU - Thomas F Gajewski
PY - 2026
DA - 2026/11/06
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0415
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0415
SN - 2051-1426
ER -